Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Helyezés a részvények között #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Részvényárfolyam
$0.00023723
Utolsó szinkronizálás: 2024-08-26
Piaci kapitalizáció
$1.41K
Változás (1 nap)
111.67%
Változás (1 év)
0.00%
Ország
FR
Kereskedés Pharnext S.A. (ALPHA)

Kategória

Pharnext S.A. (ALPHA) osztalékhozamának története
Pharnext S.A. (tőzsdei szimbólum: ALPHA) osztalékhozama (TTM) 2022-12-31 állapot szerint: 0.00%
Átlagos osztalékhozam az elmúlt 5 évben: 0.00%
Pharnext S.A. (ALPHA) osztalékhozamainak története 2012 és 2026 között
Éves záró osztalékhozam (TTM)
Év Osztalékhozam Változtassa meg
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
Hasonló cégek vagy versenytársak osztalékhozamai (TTM)